For the millions of migraine sufferers who can’t get relief from currently available medications, a new kind of drug may offer hope. Two recent studies showed that ubrogepant (Ubrelvy; Allergan), an oral calcitonin gene-related peptide (CGRP) receptor antagonist, was significantly more effective than placebo at reducing migraine pain. Freedom From …